USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q/A on Nov 19, 2026Score 11/3058% below fair value
$13.16−0.06 (-0.45%)
Close on Nov 19, 2026Market cap $243.15MP/E –Yield –
USANA Health Sciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
USANA Health Sciences's free cash flow for the twelve months ending Oct 3, 2026 was $29.54M, up 58.0% year over year. For fiscal 2025 it was $8.53M, down 83.3% from the year before. Over ten years it grew -20.8% a year on average. The highest annual figure on record is $145.31M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $8.53M | -83.3% |
| FY2024 | Dec 28, 2024 | $50.92M | -9.3% |
| FY2023 | Dec 30, 2023 | $56.15M | -40.0% |
| FY2022 | Dec 31, 2022 | $93.50M | -13.8% |
| FY2021 | Jan 1, 2022 | $108.46M | -25.4% |
| FY2020 | Jan 2, 2021 | $145.31M | +31.9% |
| FY2019 | Dec 28, 2019 | $110.16M | -21.7% |
| FY2018 | Dec 29, 2018 | $140.69M | +27.3% |
| FY2017 | Dec 30, 2017 | $110.55M | +6.1% |
| FY2016 | Dec 31, 2016 | $104.19M | +18.8% |
| FY2015 | Jan 2, 2016 | $87.74M | +3.5% |
| FY2014 | Jan 3, 2015 | $84.76M | -6.7% |
| FY2013 | Dec 28, 2013 | $90.84M | +7.7% |
| FY2012 | Dec 29, 2012 | $84.37M | +41.9% |
| FY2011 | Dec 31, 2011 | $59.47M | -4.0% |
| FY2010 | Jan 1, 2011 | $61.92M | +118.5% |
| FY2009 | Jan 2, 2010 | $28.34M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 3, 2026 | $8.44M | – |
| Q2 FY2026 | Jul 4, 2026 | $20.16M | +180.4% |
| Q1 FY2026 | Apr 4, 2026 | $7.11M | -43.9% |
| Q4 FY2025 | Jan 3, 2026 | -$6.19M | -255.3% |
| Q3 FY2025 | Sep 27, 2025 | -$5.16M | -119.0% |
| Q2 FY2025 | Jun 28, 2025 | $7.19M | +35.2% |
| Q1 FY2025 | Mar 29, 2025 | $12.68M | -12.4% |
| Q4 FY2024 | Dec 28, 2024 | $3.98M | -78.7% |
| Q3 FY2024 | Sep 28, 2024 | $27.14M | +30.6% |
| Q2 FY2024 | Jun 29, 2024 | $5.32M | -10.5% |
| Q1 FY2024 | Mar 30, 2024 | $14.48M | +35.0% |
| Q4 FY2023 | Dec 30, 2023 | $18.70M | -49.7% |
| Q3 FY2023 | Sep 30, 2023 | $20.78M | -18.7% |
| Q2 FY2023 | Jul 1, 2023 | $5.94M | -53.8% |
| Q1 FY2023 | Apr 1, 2023 | $10.73M | -40.1% |
| Q4 FY2022 | Dec 31, 2022 | $37.18M | +70.8% |
| Q3 FY2022 | Oct 1, 2022 | $25.55M | -17.7% |
| Q2 FY2022 | Jul 2, 2022 | $12.87M | -65.8% |
| Q1 FY2022 | Apr 2, 2022 | $17.91M | -0.8% |
| Q4 FY2021 | Jan 1, 2022 | $21.77M | -53.1% |
| Q3 FY2021 | Oct 2, 2021 | $31.02M | -33.0% |
| Q2 FY2021 | Jul 3, 2021 | $37.61M | +29.3% |
| Q1 FY2021 | Apr 3, 2021 | $18.06M | -23.2% |
| Q4 FY2020 | Jan 2, 2021 | $46.43M | -8.1% |
| Q3 FY2020 | Sep 26, 2020 | $46.27M | +0.4% |
| Q2 FY2020 | Jun 27, 2020 | $29.08M | +174.2% |
| Q1 FY2020 | Mar 28, 2020 | $23.52M | +698.9% |
| Q4 FY2019 | Dec 28, 2019 | $50.54M | +33.5% |
| Q3 FY2019 | Sep 28, 2019 | $46.07M | -11.9% |
| Q2 FY2019 | Jun 29, 2019 | $10.61M | -68.8% |
| Q1 FY2019 | Mar 30, 2019 | $2.94M | -82.2% |
| Q4 FY2018 | Dec 29, 2018 | $37.86M | -25.9% |
| Q3 FY2018 | Sep 29, 2018 | $52.27M | +382.3% |
| Q2 FY2018 | Jun 30, 2018 | $33.99M | -32.2% |
| Q1 FY2018 | Mar 31, 2018 | $16.57M | – |
| Q4 FY2017 | Dec 30, 2017 | $51.08M | +5.3% |
| Q3 FY2017 | Sep 30, 2017 | $10.84M | – |
| Q2 FY2017 | Jul 1, 2017 | $50.12M | – |
| Q1 FY2017 | Apr 1, 2017 | -$1.48M | – |
| Q4 FY2016 | Dec 31, 2016 | $48.50M | – |
See a number that looks wrong?